应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06160 百济神州
休市中 04-19 16:08:35
77.000
-2.200
-2.78%
最高
79.200
最低
75.450
成交量
181.14万
今开
79.200
昨收
79.200
日振幅
4.73%
总市值
1,047亿
流通市值
1,047亿
总股本
13.60亿
成交额
1.39亿
换手率
0.13%
流通股本
13.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
百济神州04月19日主力资金流入641万元 连续7日加仓
自选股智能写手 · 04-19 16:15
百济神州04月19日主力资金流入641万元 连续7日加仓
百济神州获融资买入0.13亿元,近三日累计买入0.29亿元
金融界 · 04-19 08:21
百济神州获融资买入0.13亿元,近三日累计买入0.29亿元
真坑!基民喊话万家基金黄兴亮:你被菜市大妈吊打了
深蓝财经 · 04-18 18:52
真坑!基民喊话万家基金黄兴亮:你被菜市大妈吊打了
百济神州04月17日主力资金流入412万元 连续5日加仓
自选股智能写手 · 04-17
百济神州04月17日主力资金流入412万元 连续5日加仓
港股概念追踪 |北京支持创新医药高质量发展政策出台 机构看好国产创新药产业链崛起(附概念股)
智通财经 · 04-17
港股概念追踪 |北京支持创新医药高质量发展政策出台 机构看好国产创新药产业链崛起(附概念股)
【券商聚焦】招银国际料今年中国医药行业有望回归健康增长
金吾财讯 · 04-16
【券商聚焦】招银国际料今年中国医药行业有望回归健康增长
南向资金4月15日净买入百济神州23.99万股 连续3日增持
自选股智能写手 · 04-16
南向资金4月15日净买入百济神州23.99万股 连续3日增持
北向资金4月15日净买入百济神州-U1.57万股 连续3日增持
自选股智能写手 · 04-16
北向资金4月15日净买入百济神州-U1.57万股 连续3日增持
百济神州(06160):建议授予董事受限制股份单位及业绩股份单位
智通财经 · 04-16
百济神州(06160):建议授予董事受限制股份单位及业绩股份单位
百济神州04月15日主力资金流入198万元 连续3日加仓
自选股智能写手 · 04-15
百济神州04月15日主力资金流入198万元 连续3日加仓
百济神州(上海)生物科技有限公司药品申请临床试验默示许可获受理
金融界 · 04-15
百济神州(上海)生物科技有限公司药品申请临床试验默示许可获受理
百济神州(688235)4月11日主力资金净卖出707.29万元
证券之星 · 04-12
百济神州(688235)4月11日主力资金净卖出707.29万元
百济神州下跌2.18%,报146.5美元/股
金融界 · 04-11
百济神州下跌2.18%,报146.5美元/股
百济神州(06160)下跌5.04%,报88.5元/股
金融界 · 04-11
百济神州(06160)下跌5.04%,报88.5元/股
百济神州(06160)股价下跌5.043%,现价港币$88.5
阿斯达克财经 · 04-11
百济神州(06160)股价下跌5.043%,现价港币$88.5
百济神州(688235)4月10日主力资金净买入402.30万元
证券之星 · 04-11
百济神州(688235)4月10日主力资金净买入402.30万元
《大行》美银证券降百济神州(06160.HK)目标价至99.21元 评级“中性”
阿斯达克财经 · 04-10
《大行》美银证券降百济神州(06160.HK)目标价至99.21元 评级“中性”
百济神州-U4月9日获北向资金加仓25.15万股
自选股智能写手 · 04-10
百济神州-U4月9日获北向资金加仓25.15万股
肿瘤创新药“广州造”,粤港澳大湾区首个ADC生产基地启用
南方都市报 · 04-09
肿瘤创新药“广州造”,粤港澳大湾区首个ADC生产基地启用
北向资金4月8日净买入百济神州-U12.67万股 连续3日增持
自选股智能写手 · 04-09
北向资金4月8日净买入百济神州-U12.67万股 连续3日增持
公司概况
公司名称:
百济神州
所属市场:
SEHK
上市日期:
--
主营业务:
百济神州有限公司是一家主要从事生物制药业务的公司。该公司主要从事用于治疗癌症的创新分子靶向及免疫肿瘤药物的研发,生产和销售业务。该公司的主要产品包括Zanubrutinib(BGB-3111),Tislelizumab(BGB-A317)和Pamiparib(BGB-290)等。
发行价格:
--
{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":77,"timestamp":1713514115035,"preClose":79.2,"halted":0,"volume":1811384,"delay":0,"floatShares":1359524369,"shares":1359524369,"eps":-5.088347,"marketStatus":"休市中","marketStatusCode":7,"change":-2.2,"latestTime":"04-19 16:08:35","open":79.2,"high":79.2,"low":75.45,"amount":138955762,"amplitude":0.047348,"askPrice":77,"askSize":14700,"bidPrice":76.95,"bidSize":10400,"shortable":3,"etf":0,"ttmEps":-5.088346777351398,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1533657600000,"adjPreClose":79.2,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.7835119880203432,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":116.3,"timestamp":1713510000000,"preClose":118.21,"halted":0,"volume":1334427,"delay":0,"premium":"-38.69"}},"requestUrl":"/m/hq/s/06160/wiki","defaultTab":"wiki","newsList":[{"id":"2428638481","title":"百济神州04月19日主力资金流入641万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428638481","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428638481?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514540,"startTime":"0","endTime":"0","summary":"04月19日, 百济神州股价跌2.78%,报收77.00元,成交金额1.39亿元,换手率0.15%,振幅4.73%,量比1.78。百济神州今日主力资金净流入641万元,连续7日净流入,上一交易日主力净流入608万元,今日环比增加5.43%。近一年数据显示,该股主力连续7日净流入后,次日上涨概率为60.00%,平均涨幅为1.85%。该股近5个交易日下跌10.39%,主力资金累计净流入2275万元;近20日主力资金累计净流入3480万元,其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615598794aef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615598794aef3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428520381","title":"百济神州获融资买入0.13亿元,近三日累计买入0.29亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428520381","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2428520381?lang=zh_cn&edition=full","pubTime":"2024-04-19 08:21","pubTimestamp":1713486102,"startTime":"0","endTime":"0","summary":"4月18日,沪深两融数据显示,百济神州获融资买入额0.13亿元,居两市第601位,当日融资偿还额0.06亿元,净买入707.20万元。最近三个交易日,16日-18日,百济神州分别获融资买入0.06亿元、0.10亿元、0.13亿元。融券方面,当日融券卖出0.54万股,净买入0.59万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190821478792723c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190821478792723c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428597614","title":"真坑!基民喊话万家基金黄兴亮:你被菜市大妈吊打了","url":"https://stock-news.laohu8.com/highlight/detail?id=2428597614","media":"深蓝财经","top":-1,"share":"https://www.laohu8.com/m/news/2428597614?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:52","pubTimestamp":1713437527,"startTime":"0","endTime":"0","summary":"■ 传疯了!诺安基金前顶流蔡嵩松获刑?本人回应...■ 民生银行踩雷地产,董事长年薪大降至373万,但仍是“年薪一哥”来源 | 深蓝财经撰文 | 王鑫随着前明星基金经理蔡嵩松受贿案的细节曝光,原来公募为游资接盘的传闻都是真的,这无疑给公募基金行业丢下了一颗重磅炸弹,基金经理们还值得信任吗?近两三年,“基...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OPmmoSTeuGWgoMEM2VuJdws8ZG3E-gEqA5zY-OcV1fLMEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OPmmoSTeuGWgoMEM2VuJdws8ZG3E-gEqA5zY-OcV1fLMEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240418A08BUW00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240418A08BUW00","is_publish_highlight":false,"gpt_icon":0},{"id":"2428930323","title":"百济神州04月17日主力资金流入412万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428930323","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428930323?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:16","pubTimestamp":1713341804,"startTime":"0","endTime":"0","summary":"04月17日, 百济神州股价跌1.28%,报收81.05元,成交金额9062万元,换手率0.09%,振幅3.41%,量比1.21。百济神州今日主力资金净流入412万元,连续5日净流入,上一交易日主力净流入414万元,今日环比减少0.48%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为50.00%,平均涨幅为4.58%。该股近5个交易日下跌12.88%,主力资金累计净流入1276万元;近20日主力资金累计净流入1772万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617118787fd40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171617118787fd40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428741365","title":"港股概念追踪 |北京支持创新医药高质量发展政策出台 机构看好国产创新药产业链崛起(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2428741365","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428741365?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:10","pubTimestamp":1713334218,"startTime":"0","endTime":"0","summary":"北京市医疗保障局、北京市药品监督管理局等多部门发布北京市支持创新医药高质量发展若干措施。近日,北京、广州、珠海等多地政府先后发布了支持创新药高质量发展的利好政策,从多个产业链条环节发布相应支持政策,全方位促进创新药发展。康哲药业:创新药高选择性TYK2抑制剂CMS-D001及GnRH受体拮抗剂CMS-D002获药物临床试验批准通知书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103769.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427139158","title":"【券商聚焦】招银国际料今年中国医药行业有望回归健康增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2427139158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2427139158?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:56","pubTimestamp":1713250565,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示,年初至今,MSCI中国医疗指数下跌22.7%,跑输MSCI中国指数23.3%。展望2024年,随着行业监管常态化进行,新冠基数影响逐渐消退,中国医药行业有望回归健康增长。另外,行业监管仍呈现持续高压态势,预计院内刚需将在下半年出现需求复苏。该行认为,行业严格监管或将常态化,然而,诊疗秩序逐步正常,院内产品和服务的需求仍将保持健康。考虑到基数原因,该行预期行业或将于今年下半年加速增长。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935150","is_publish_highlight":false,"gpt_icon":0},{"id":"2427850430","title":"南向资金4月15日净买入百济神州23.99万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427850430","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427850430?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:31","pubTimestamp":1713231090,"startTime":"0","endTime":"0","summary":"4月15日, 南向资金增持百济神州23.99万股,连续3日增持。截止当日收盘,港股通共持有百济神州5226.30万股,占流通股3.84%。百济神州近5个交易日下跌6.72%,港股通累计增持27.33万股;近20个交易日下跌19.00%,港股通累计增持364.33万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160943538781e7cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160943538781e7cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427850259","title":"北向资金4月15日净买入百济神州-U1.57万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427850259","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427850259?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:30","pubTimestamp":1713231036,"startTime":"0","endTime":"0","summary":"4月15日, 北向资金增持百济神州-U1.57万股,连续3日增持。截止当日收盘,沪股通共持有百济神州-U531.20万股,占流通股4.61%。沪股通增持金额前五个股分别为贵州茅台、中国建筑、山西汾酒、兴业银行、招商银行。百济神州-U近5个交易日下跌2.38%,沪股通累计增持24.74万股;近20个交易日下跌10.75%,沪股通累计增持128.51万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160935088781df2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160935088781df2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427853720","title":"百济神州(06160):建议授予董事受限制股份单位及业绩股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2427853720","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427853720?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:37","pubTimestamp":1713224265,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州 发布公告,董事会已议决根据2016年计划建议授予受限制股份单位及业绩股份单位如下,但须获接纳及于股东周年大会上获独立股东批准方可作实:授予欧雷强先生于授予日期公平值为600万美元的受限制股份单位;授予欧雷强先生于授予日期公平值为600万美元的业绩股份单位;授予王晓东博士于授予日期公平值为133.33万美元的受限制股份单位;及授予各独立非执行董事于授予日期公平值为20万美元的受限制股份单位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103026.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427025884","title":"百济神州04月15日主力资金流入198万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427025884","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427025884?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:16","pubTimestamp":1713168982,"startTime":"0","endTime":"0","summary":"04月15日, 百济神州股价跌1.98%,报收84.00元,成交金额8771万元,换手率0.08%,振幅4.08%,量比1.23。百济神州今日主力资金净流入198万元,连续3日净流入,上一交易日主力净流入58万元,今日环比增加241.38%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为35.71%,平均涨幅为1.60%。该股近5个交易日下跌6.72%,主力资金累计净流入381万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入4004万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161650877e8ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415161650877e8ef3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427921044","title":"百济神州(上海)生物科技有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2427921044","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427921044?lang=zh_cn&edition=full","pubTime":"2024-04-15 15:02","pubTimestamp":1713164560,"startTime":"0","endTime":"0","summary":"4月15日,据CDE官网消息,百济神州(上海)生物科技有限公司联合申请药品“替雷利珠单抗注射液”,获得临床试验默示许可,受理号CXSB2400009。公示信息显示,药品“替雷利珠单抗注射液”适应症:替雷利珠单抗联合Ociperlimab用于非小细胞肺癌的治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415150523877e3b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415150523877e3b04&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426217767","title":"百济神州(688235)4月11日主力资金净卖出707.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426217767","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426217767?lang=zh_cn&edition=full","pubTime":"2024-04-12 07:53","pubTimestamp":1712879631,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月11日收盘,百济神州报收于126.99元,下跌3.18%,换手率0.9%,成交量1.03万手,成交额1.33亿元。近5日资金流向一览见下表:百济神州融资融券信息显示,融资方面,当日融资买入557.39万元,融资偿还541.2万元,融资净买入16.18万元。百济神州主营业务:研究、开发、生产以及商业化创新型药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041200010606.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426692332","title":"百济神州下跌2.18%,报146.5美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426692332","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426692332?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:56","pubTimestamp":1712847394,"startTime":"0","endTime":"0","summary":"4月11日,百济神州(BGNE)盘中下跌2.18%,截至22:56,报146.5美元/股,成交903.48万美元。财务数据显示,截至2023年12月31日,百济神州收入总额24.59亿美元,同比增长73.65%;归母净利润-8.82亿美元,同比增长56.0%。大事提醒:4月8日,百济神州获美国银行下调目标价至164.3美元,最新评级Neutral。5月2日,百济神州将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/11225640205824.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426066224","title":"百济神州(06160)下跌5.04%,报88.5元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426066224","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426066224?lang=zh_cn&edition=full","pubTime":"2024-04-11 11:22","pubTimestamp":1712805723,"startTime":"0","endTime":"0","summary":"4月11日,百济神州(06160)盘中下跌5.04%,截至11:22,报88.5元/股,成交4451.78万元。百济神州有限公司是一家专注于开发和商业化用于治疗癌症的创新型分子靶向和肿瘤免疫治疗药物的生物技术公司。公司拥有包括六种内部开发的临床阶段候选药物和五种获得授权许可的药物在内的广泛产品组合,以及超过1300名员工的全球团队。截至2023年年报,百济神州营业总收入174.15亿元、净利润-62.45亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/11112240195394.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426593406","title":"百济神州(06160)股价下跌5.043%,现价港币$88.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2426593406","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426593406?lang=zh_cn&edition=full","pubTime":"2024-04-11 11:20","pubTimestamp":1712805600,"startTime":"0","endTime":"0","summary":"[下跌股]百济神州(06160) 股价在上午11:20比前收市价下跌5.043%,现股价为港币$88.5。至目前为止,今日最高价为$90.6,而最低价为$88.5。总成交量为47.68万股,总成交金额为港币$4.272千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240411964/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426842030","title":"百济神州(688235)4月10日主力资金净买入402.30万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426842030","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426842030?lang=zh_cn&edition=full","pubTime":"2024-04-11 07:53","pubTimestamp":1712793226,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月10日收盘,百济神州报收于131.16元,上涨0.52%,换手率1.04%,成交量1.2万手,成交额1.57亿元。近5日资金流向一览见下表:百济神州融资融券信息显示,融资方面,当日融资买入269.55万元,融资偿还1040.12万元,融资净偿还770.57万元。百济神州主营业务:研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041100009701.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426048188","title":"《大行》美银证券降百济神州(06160.HK)目标价至99.21元 评级“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2426048188","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426048188?lang=zh_cn&edition=full","pubTime":"2024-04-10 12:01","pubTimestamp":1712721660,"startTime":"0","endTime":"0","summary":"美银证券发表研究报告指,百济神州自研药物帕米帕利2月销售额为60万元人民币,按年跌27.8%,按月跌43.2%,而替雷利珠单抗、Zanubrutinib的销售额则分别为1.609亿和4,470万元人民币,按年增长51.9%及26.4%,按月则降31%及32%。2月药品销售按月下降主要是受到农历新年的影响。该行表示,鉴于中国市场上PARP抑制剂和其他生物类似药产品的激烈竞争,将目标价由108.27元下调至99.21元,并重申“中性”评级。(港股报价延迟最少十五分钟。沽空资料截至 2024-04-09 16:25。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210201153351459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210201153351459_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1341255/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426105895","title":"百济神州-U4月9日获北向资金加仓25.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426105895","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426105895?lang=zh_cn&edition=full","pubTime":"2024-04-10 09:30","pubTimestamp":1712712637,"startTime":"0","endTime":"0","summary":"4月9日, 北向资金增持百济神州-U25.15万股,连续4日增持。截止当日收盘,沪股通共持有百济神州-U531.61万股,占流通股4.62%。沪股通增持金额前五个股分别为紫金矿业、海尔智家、赤峰黄金、中金黄金、洛阳钼业。百济神州-U近5个交易日下跌1.30%,沪股通累计增持47.79万股;近20个交易日上涨2.97%,沪股通累计增持227.56万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100935168b064b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100935168b064b35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426184735","title":"肿瘤创新药“广州造”,粤港澳大湾区首个ADC生产基地启用","url":"https://stock-news.laohu8.com/highlight/detail?id=2426184735","media":"南方都市报","top":-1,"share":"https://www.laohu8.com/m/news/2426184735?lang=zh_cn&edition=full","pubTime":"2024-04-09 12:14","pubTimestamp":1712636046,"startTime":"0","endTime":"0","summary":"4月8日,创新药企百济神州位于中新广州知识城的广州大分子生物药生产基地抗体偶联药物生产园区竣工启用,这不仅是广州第一个、也是粤港澳大湾区的首个ADC生产基地。位于广州生物药生产基地南园的ADC生产园区,占地5.8万平方米,将成为百济神州ADC药物研发和生产的核心基地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091215578b0141dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404091215578b0141dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426861909","title":"北向资金4月8日净买入百济神州-U12.67万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426861909","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426861909?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:30","pubTimestamp":1712626238,"startTime":"0","endTime":"0","summary":"4月8日, 北向资金增持百济神州-U12.67万股,连续3日增持。截止当日收盘,沪股通共持有百济神州-U506.46万股,占流通股4.40%。沪股通增持金额前五个股分别为海尔智家、山西汾酒、兴业银行、韦尔股份、工商银行。百济神州-U近5个交易日下跌2.79%,沪股通累计增持21.60万股;近20个交易日上涨1.79%,沪股通累计增持233.74万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090936458756a0af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090936458756a0af&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beigene.com","stockEarnings":[{"period":"1week","weight":-0.1015},{"period":"1month","weight":-0.2495},{"period":"3month","weight":-0.1929},{"period":"6month","weight":-0.1865},{"period":"1year","weight":-0.5019},{"period":"ytd","weight":-0.3006}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百济神州有限公司是一家主要从事生物制药业务的公司。该公司主要从事用于治疗癌症的创新分子靶向及免疫肿瘤药物的研发,生产和销售业务。该公司的主要产品包括Zanubrutinib(BGB-3111),Tislelizumab(BGB-A317)和Pamiparib(BGB-290)等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03281},{"month":2,"riseRate":0.5,"avgChangeRate":0.020001},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.060772},{"month":4,"riseRate":0.5,"avgChangeRate":0.021138},{"month":5,"riseRate":0.4,"avgChangeRate":-0.051509},{"month":6,"riseRate":0.6,"avgChangeRate":0.018734},{"month":7,"riseRate":0.8,"avgChangeRate":0.062642},{"month":8,"riseRate":0.8,"avgChangeRate":0.040871},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.025087},{"month":10,"riseRate":0.666667,"avgChangeRate":0.006083},{"month":11,"riseRate":0.5,"avgChangeRate":0.130955},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.054912}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}